<code id='924D410267'></code><style id='924D410267'></style>
    • <acronym id='924D410267'></acronym>
      <center id='924D410267'><center id='924D410267'><tfoot id='924D410267'></tfoot></center><abbr id='924D410267'><dir id='924D410267'><tfoot id='924D410267'></tfoot><noframes id='924D410267'>

    • <optgroup id='924D410267'><strike id='924D410267'><sup id='924D410267'></sup></strike><code id='924D410267'></code></optgroup>
        1. <b id='924D410267'><label id='924D410267'><select id='924D410267'><dt id='924D410267'><span id='924D410267'></span></dt></select></label></b><u id='924D410267'></u>
          <i id='924D410267'><strike id='924D410267'><tt id='924D410267'><pre id='924D410267'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:463
          Mississippi Delta Region, pulse oximeter
          Pulse oximeters, which track blood oxygen levels, can overestimate such levels in patients with darker skin, potentially providing reassurance instead of indicating they need to be treated. Spencer Platt/Getty Images

          LONDON — Regulators, clinicians, and health care algorithm developers need to take additional steps to ensure that medical devices work equally well for all patients, avoiding blind spots that can lead to worse care for patients from underrepresented racial and ethnic groups, according to a U.K.-commissioned review released on Monday.

          The report, which also warned about the products’ biases potentially hurting women and people from lower socioeconomic groups, called on the government to improve its understanding of the devices used commonly in the country’s health service, with a need for an expert panel that can assess the possible unintended consequences as AI tools expand. Providers also need to learn about the limitations of these devices, to ensure they don’t result in poor patient care.

          advertisement

          The report cited several examples, including evidence that pulse oximeters, which track blood oxygen levels, can overestimate such levels in patients with darker skin, potentially providing reassurance instead of indicating they need to be treated.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case
          City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

          FILE-InthisimagetakenfromvideoreleasedonJan.27,2023,bythecityofMemphis,Tenn.,TyreNicholsleansagainst

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          In diabetes hearing, Sanders takes on a new foe: food makers

          Sen.BerneSanders(I-Vt.)KevinDietsch/GettyImagesWASHINGTON—Sen.BernieSanders(I-Vt.)hasanewcorporateta